Anti-cd19 antibodies

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/395 (2006.01) A61K 51/00 (2006.01) C07K 16/00 (2006.01) C07K 16/46 (2006.01)

Patent

CA 2534639

The present invention provides humanized, chimeric and human anti-CD19 antibodies, anti-CD19 antibody fusion proteins, and fragments thereof that bind to a human B cell marker. Such antibodies, fusion proteins and fragments thereof are useful for the treatment and diagnosis of various B-cell disorders, including B-cell malignancies and autoimmune diseases.

La présente invention concerne des anticorps anti-CD19 humains, chimériques et humanisés, des protéines hybrides d'anticorps anti-CD19, et des fragments de ceux-ci se liant à un marqueur de lymphocyte B humain. Ces anticorps, ces protéines hybrides et ces fragments sont particulièrement utiles pour traiter et diagnostiquer divers troubles liés aux lymphocytes B, y compris la malignité des lymphocytes B et les maladies auto-immunes.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Anti-cd19 antibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Anti-cd19 antibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-cd19 antibodies will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1427824

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.